Literature DB >> 31734762

Time-updated resting heart rate predicts mortality in patients with COPD.

Albert J Omlor1, Franziska C Trudzinski1, Mohamad Alqudrah1, Frederik Seiler1, Frank Biertz2, Claus F Vogelmeier3, Tobias Welte4, Henrik Watz5, Benjamin Waschki5,6, Titus J Brinker7, Stefan Andreas8,9, Sebastian Fähndrich1, Peter Alter3, Rudolf A Jörres10, Michael Böhm11, Robert Bals12.   

Abstract

High resting heart rate (RHR) is associated with higher mortality in the general population and in cardiovascular disease. Less is known about the association of RHR with outcome in chronic obstructive pulmonary disease (COPD). In particular, the time-updated RHR (most recent value before the event) appears informative. This is the first study to investigate the association of time-updated RHR with mortality in COPD. We compared the baseline and time-updated RHR related to survival in 2218 COPD patients of the German COSYCONET cohort (COPD and Systemic Consequences-Comorbidities Network). Patients with a baseline RHR > 72 beats per minute (bmp) had a significantly (p = 0.049) higher all-cause mortality risk (adjusted hazard ratio (HR) of 1.37 (1.00-1.87) compared to baseline RHR ≤ 72 bpm. The time-updated RHR > 72 bpm was markedly superior (HR 1.79, 1.30-2.46, p = 0.001). Both, increased baseline and time-updated RHR, were independently associated with low FEV1, low TLCO, a history of diabetes, and medication with short-acting beta agonists (SABAs). In conclusion, increased time-updated RHR is associated with higher mortality in COPD independent of other predictors and superior to baseline RHR. Increased RHR is linked to lung function, comorbidities and medication. Whether RHR is an effective treatment target in COPD, needs to be proven in controlled trials.

Entities:  

Keywords:  COPD; COSYCONET; Comorbidity; Heart rate; Mortality

Mesh:

Year:  2019        PMID: 31734762     DOI: 10.1007/s00392-019-01572-1

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  4 in total

1.  Sex-specific associations of comorbidome and pulmorbidome with mortality in chronic obstructive pulmonary disease: results from COSYCONET.

Authors:  Franziska C Trudzinski; Rudolf A Jörres; Peter Alter; Julia Walter; Henrik Watz; Andrea Koch; Matthias John; Marek Lommatzsch; Claus F Vogelmeier; Hans-Ulrich Kauczor; Tobias Welte; Jürgen Behr; Amanda Tufman; Robert Bals; Felix J F Herth; Kathrin Kahnert
Journal:  Sci Rep       Date:  2022-05-24       Impact factor: 4.996

2.  Admission Resting Heart Rate as an Independent Predictor of All-Cause Mortality in Elderly Patients with Hip Fracture.

Authors:  Zhicong Wang; Xi Chen; Yuxuan Wu; Wei Jiang; Ling Yang; Hong Wang; Shuping Liu; Yuehong Liu
Journal:  Int J Gen Med       Date:  2021-11-04

3.  Association of β-blocker use with survival and pulmonary function in patients with chronic obstructive pulmonary and cardiovascular disease: a systematic review and meta-analysis.

Authors:  Yan-Li Yang; Zi-Jian Xiang; Jing-Hua Yang; Wen-Jie Wang; Zhi-Chun Xu; Ruo-Lan Xiang
Journal:  Eur Heart J       Date:  2020-12-07       Impact factor: 29.983

4.  Five-year results of heart rate control with ivabradine or metoprolol succinate in patients after heart transplantation.

Authors:  Rasmus Rivinius; Matthias Helmschrott; Ann-Kathrin Rahm; Fabrice F Darche; Dierk Thomas; Tom Bruckner; Andreas O Doesch; Hugo A Katus; Philipp Ehlermann
Journal:  Clin Res Cardiol       Date:  2020-06-22       Impact factor: 5.460

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.